Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA approves Novo Nordisk's Tretten to treat rare genetic clotting disorder
FDA approves Novo Nordisk's Tretten to treat rare genetic clotting disorder
FDA approves Novo Nordisk's Tretten to treat rare genetic clotting disorder
Submitted by
admin
on December 23, 2013 - 3:22pm
Source:
Yahoo/Fly on the Wall
News Tags:
Novo Nordisk
Tretten
FDA
congenital Factor XIII A-subunit deficiency
Headline:
FDA approves Novo Nordisk's Tretten to treat rare genetic clotting disorder
Do Not Allow Advertisers to Use My Personal information
